Chemistry and Pharmacology of Newly Emerging Psychoactive Plants

新出现的精神活性植物的化学和药理学

基本信息

  • 批准号:
    7471601
  • 负责人:
  • 金额:
    $ 7.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In recent years new psychoactive plants and their active secondary metabolites have been emerging on the streets. An example is the strong hallucinogenic mint Salvia divinorum and its active metabolite salvinorin A. This use of new hallucinogens unregulated by Federal and most State laws is spreading across the country and globally. The plants are easily obtained on numerous internet sites and have a high potential of becoming street drugs in the near future. Despite their ready availability the chemistry and pharmacology of these substances are largely unknown. In most cases neither the active constituents of these plants nor the mechanism of their interaction with the central nervous system have been determined. The purpose of this project is study the chemistry and pharmacology of lesser known emerging psychoactive plants with purported hallucinogenic or sedative activity. For this project we have selected 15 potent hallucinogenic/sedative plant species with little known chemistry and pharmacology. We propose to biologically evaluate these plants against the battery of CNS receptors under NIMH Psychoactive Drug Screening Program at the University of North Carolina at Chapel Hill and isolate the active secondary metabolites responsible for hallucinogenic and other psychotropic effects. In the long-term new ligands to CNS-receptors discovered and developed in this project will contribute to better knowledge of the central nervous system functions and its disorders. To achieve these goals, the following specific aims will be pursued: 1. Acquisition of selected plant species from botanical gardens, private collections or commercial brokers. 2. Selective extraction of biological material. 3. Biological evaluation of extracts for affinity to CNS neurotransmitters receptors. 4. Bioassay-guided fractionation and isolation of active secondary metabolites. 5. Structure elucidation of isolated metabolites and their biological re-evaluation in the specific receptor systems. 6. Chemical transformations of lead compounds. The data generated by this project will form a basis for further research and provide preliminary results for seeking more extensive funding. PUBLIC HEALTH RELEVANCE With the growing number of newly emerging hallucinogens on the streets, the concern of the health of people, especially youth, becomes a very important issue. For many hallucinogenic plants used we do not know their mechanism of action in central nervous system, their potential to become addictive drugs of abuse, their toxicity to vital organs and systems of human body or other side effects. Our project on the chemistry and pharmacology of newly emerging psychoactive plants will address these issues and provide information to further research in this area.
描述(由申请人提供):近年来,新的精神活性植物及其活性次级代谢产物已经出现在街道上。一个例子是强烈的致幻薄荷鼠尾草(Salvia divinorum)及其活性代谢物鼠尾草素A。这种不受联邦和大多数州法律管制的新型致幻剂的使用正在全国和全球范围内蔓延。这些植物很容易在许多互联网网站上获得,并且在不久的将来很有可能成为街头毒品。尽管它们容易获得,但这些物质的化学和药理学在很大程度上是未知的。在大多数情况下,这些植物的活性成分和它们与中枢神经系统相互作用的机制都还没有确定。这个项目的目的是研究具有致幻或镇静作用的鲜为人知的新兴精神活性植物的化学和药理学。在这个项目中,我们选择了15种化学和药理学知之甚少的强效致幻/镇静植物。我们建议根据查佩尔山的北卡罗来纳州大学的NIMH精神活性药物筛选计划,对这些植物的CNS受体电池进行生物学评价,并分离出负责致幻和其他精神作用的活性次级代谢产物。从长远来看,本项目中发现和开发的CNS受体新配体将有助于更好地了解中枢神经系统功能及其疾病。为实现这些目标,将努力实现以下具体目标:1.从植物园、私人收藏品或商业经纪人处收购选定的植物物种。2.选择性提取生物材料。3.提取物对CNS神经递质受体亲和力的生物学评价。4.活性次级代谢产物的生物测定引导的分级分离。5.代谢产物的结构解析及其在特定受体系统中的生物学再评价。6.铅化合物的化学转化。该项目产生的数据将成为进一步研究的基础,并为寻求更广泛的资金提供初步结果。随着街头新出现的致幻剂越来越多,人们,特别是青少年的健康问题变得非常重要。对于许多使用的致幻植物,我们不知道它们在中枢神经系统中的作用机制,它们成为滥用成瘾药物的潜力,它们对人体重要器官和系统的毒性或其他副作用。我们的新出现的精神活性植物的化学和药理学项目将解决这些问题,并为这一领域的进一步研究提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JORDAN K ZJAWIONY其他文献

JORDAN K ZJAWIONY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JORDAN K ZJAWIONY', 18)}}的其他基金

Psychopharmacology of plants and their metabolites used as marijuana substitutes
用作大麻替代品的植物及其代谢物的精神药理学
  • 批准号:
    8046170
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
Psychopharmacology of plants and their metabolites used as marijuana substitutes
用作大麻替代品的植物及其代谢物的精神药理学
  • 批准号:
    8279212
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
Chemistry and Pharmacology of Newly Emerging Psychoactive Plants
新出现的精神活性植物的化学和药理学
  • 批准号:
    7817054
  • 财政年份:
    2009
  • 资助金额:
    $ 7.16万
  • 项目类别:
MISSISSIPPI COBRE: CORE B: CHEMISTRY CORE
密西西比 COBRE:核心 B:化学核心
  • 批准号:
    7610762
  • 财政年份:
    2007
  • 资助金额:
    $ 7.16万
  • 项目类别:
MISSISSIPPI COBRE: CORE B: CHEMISTRY CORE
密西西比 COBRE:核心 B:化学核心
  • 批准号:
    7382242
  • 财政年份:
    2006
  • 资助金额:
    $ 7.16万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 7.16万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了